InvestorsHub Logo
Followers 7
Posts 344
Boards Moderated 0
Alias Born 08/04/2016

Re: None

Friday, 07/21/2023 8:03:01 AM

Friday, July 21, 2023 8:03:01 AM

Post# of 426487
Courtesy of SW poster. There’s also a graph on SW that depicts the timeline. In short, Denners MDCO playbook is very similar to Amarins—hoping the outcome will be too.


evila
3:46 AM
$AMRN MDCO:
Dec 10 2018: Share Price = $21.32 before markets open
Dec 10 2018: Mark Timney is appointed new CEO. Base salary = $600,000 with annual bonus equal to 65% of his base salary based on achievement of annual objectives determined by the board. The Employment Agreement also contemplates Mr. Timney’s agreement to purchase in the open market a number of shares equal to $500,000.
Dec 12 2018: proposes to offer $150 million aggregate principal amount of convertible senior notes due 2024
Dec 13 2018: Alex Denner FORM4 shows a purchase of 819,000 shares for $20.73 and $18.97. Total amount owned = 2,741,000.
Dec 10 2018: Mark Timney FORM4 shows a purchase of 26,863 shares for $18.6, equal to 496K
Dec 21 2018: MDCO share price falls to its minimum price: $17.26. From that date onwards, share price went up until buyout
Nov 23 2019: Novartis announces MDCO acquisition at $85. Sarissa average cost basis: $27
If the story repeats, we shall see share price going up from August 1st.
Show More
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News